Arcutis Biotherapeutics Inc

ARQTNASDAQ · USD
26.41USD0.00 (+1.23%)
359

Arcutis Biotherapeutics Inc (ARQT) Straddle

ARQT straddle scan found 18 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 64.5%.

Read more

Trading a ARQT straddle lets you take a pure volatility position on Arcutis Biotherapeutics Inc without committing to a direction. Arcutis Biotherapeutics Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate ARQT straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on ARQT profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Arcutis Biotherapeutics Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the ARQT straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; and ARQ-255, a topical formulation of ARQ-252 designed to reach deeper into the skin in order to treat alopecia areata.

The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the ARQT straddle is the cleanest expression of that view. Our scanner prices every ARQT straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a ARQT straddle into a catalyst or short a ARQT straddle to harvest decay, the options straddle setups that matter are all in one place.

Mar 19, 202730.00$7.5015760%64.5%$37.50$22.506
Mar 19, 202735.00$11.2515760%60.2%$46.25$23.750
Dec 18, 202627.50$4.856660%59.9%$32.35$22.650
Jan 15, 202727.50$5.789460%59.7%$33.28$21.737
Mar 19, 202725.00$6.6515760%59.1%$31.65$18.350
Jan 15, 202730.00$6.939460%58.8%$36.93$23.0815
Nov 20, 202627.50$3.883860%58.4%$31.38$23.6313
Mar 19, 202732.50$10.2015760%58.0%$42.70$22.300
Dec 18, 202630.00$6.256660%56.9%$36.25$23.750
Dec 18, 202625.00$4.636660%56.9%$29.63$20.382

As of October 14, 2026

Find the right straddle before volatility moves

Track ARQT straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.

Start your 14-day free trial